Related Experiment Video
Updated: Jul 7, 2026

Affinity Purification of Influenza Virus Ribonucleoprotein Complexes from the Chromatin of Infected Cells
Published on: June 3, 2012
Clarithromycin inhibits progeny virus production from human influenza virus-infected host cells
Daisei Miyamoto1, Sayaka Hasegawa, Nongluk Sriwilaijaroen
1Department of Biochemistry, University of Shizuoka School of Pharmaceutical Science, Shizuoka, Japan.
Abstract:
In vitro effects of macrolide clarithromycin (CAM) on influenza A virus-infected cells were examined using plaque reduction assay by treating cells either before or after viral adsorption. The significant inhibitory effect on influenza virus infection was detected only when the cells were treated with CAM after viral adsorption. The predominant inhibitory effect was observed during 4-7th hour after viral adsorption using viral production assay. CAM did not exhibit inhibitory effects on influenza virus hemagglutination, membrane fusion and viral sialidase activities. These findings indicate that CAM acts on a middle to late stage of the viral replication cycle resulting in inhibition of progeny virus production from the infected cells.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly
Antiviral Nucleoside Inhibitors
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Bacterial DNA Synthesis

